Insight
The latest results from the PACE-C trial presented at ESTRO24
Photo from ESTRO/X

The latest results from the PACE-C trial presented at ESTRO24

ESTRO (European SocieTy for Radiotherapy and Oncology) shared a post on X: .

“Check out the latest results from the PACE-C trial that were presented at ESTRO24, comparing SBRT and MHRT for high-risk prostate cancer with ADT.”

Source: ESTRO/X

ADT cancer Cancer research ESTRO ESTRO24 MHRT OncoDaily Oncology PACE-C trial prostate cancer SBRT